CASI Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CASI and other ETFs, options, and stocks.About CASI
CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing innovative therapeutics and pharmaceutical products. The firm is also involved in developing innovative therapeutics addressing cancer and other unmet medical needs for the global market.
CEODavid A. Cory
CEODavid A. Cory
Employees233
Employees233
HeadquartersBeijing, Beijing
HeadquartersBeijing, Beijing
Founded1991
Founded1991
Employees233
Employees233
CASI Key Statistics
Market cap20.92M
Market cap20.92M
Price-Earnings ratio-0.45
Price-Earnings ratio-0.45
Dividend yield—
Dividend yield—
Average volume30.61K
Average volume30.61K
High today$1.37
High today$1.37
Low today$1.31
Low today$1.31
Open price$1.31
Open price$1.31
Volume21.02K
Volume21.02K
52 Week high$6.13
52 Week high$6.13
52 Week low$1.09
52 Week low$1.09
Stock Snapshot
With a market cap of 20.92M, CASI Pharmaceuticals(CASI) trades at $1.33. The stock has a price-to-earnings ratio of -0.45.
As of 2025-11-06, CASI Pharmaceuticals(CASI) stock has fluctuated between $1.31 and $1.37. The current price stands at $1.33, placing the stock +1.6% above today's low and -2.9% off the high.
The CASI Pharmaceuticals(CASI)'s current trading volume is 21.02K, compared to an average daily volume of 30.61K.
In the last year, CASI Pharmaceuticals(CASI) shares hit a 52-week high of $6.13 and a 52-week low of $1.09.
In the last year, CASI Pharmaceuticals(CASI) shares hit a 52-week high of $6.13 and a 52-week low of $1.09.
People also own
Based on the portfolios of people who own CASI. This list is generated using Robinhood data, and it’s not a recommendation.